Clinical Study
Efficacy of Fibrin Glue on Seroma Formation after Breast Surgery
Table 3
Comparison of tumor grade, pathology, days to seroma resolution, seroma aspirate volume, and complications for the drain and fibrin glue groups.
| Parameter | Drain | Fibrin glue | value | Number | Value | Number | Value |
| Total number of patients | 29 | — | 31 | — | — | Tumor grade
| | | | | | 1 | 4 (13.8%) | — | 5 (16.1%) | — | — | 2 | 10 (34.5%) | — | 15 (48.39%) | — | — | 3 | 14 (48.3%) | — | 11 (35.5%) | — | — | 4 | 1 (3.4%) | — | 0 (0.0) | — | 0.623 | Tumor pathology | | | | | | Invasive ductal carcinoma | 15 (51.7%) | — | 18 (58.1%) | — | — | Infiltrating ductal carcinoma | 14 (48.3%) | — | 13 (41.9%) | — | 0.531 | Complications | | | | | | Infection | 1 (3.4%) | — | 2 (6.4%) | — | 0.785
| Flap necrosis | 0 | — | 0 | — | — | Hematoma | 2 (6.9%) | — | 2 (6.4%) | — | 0.765 | Open wound | 0 | — | 0 | — | — | Seroma | 7 (24.1%) | — | 5 (16.1%) | — | 0.43 | Day seroma resolved◆ | — | 18 ± 8.6 | — | 17 ± 8.9 | 0.0968 | Aspirate volume (mL)◆ | — | 210 | — | 110 | 0.0015 |
|
|
◆Mean ± SD.
|